Brief: Evolus Announces Positive Results For Evolysse Sculpt Study
25/08/2025 13:09
Aug 25 (Reuters) - Evolus Inc EOLS.O: EVOLUS INC - ANNOUNCES POSITIVE RESULTS FOR EVOLYSSE SCULPT STUDY EVOLUS: EVOLYSSE SCULPT MET PRIMARY ENDPOINT OF NON-INFERIORITY & DEMONSTRATED STATISTICAL SUPERIORITY TO RESTYLANE-LYFT Source text: ID:nBw2128Kra Further company coverage: EOLS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe